Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20200905048630N5
IRCT20200905048630N5
Not yet recruiting
Phase 3

Investigating the effect of intraovarian administration of platelet rich plasma in patients with poor ovarian response in improving the result of assisted procedures

Bandare-abbas University of Medical Sciences0 sites88 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsReducedovarian reserve..Primary ovarian failureE28.3

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Reducedovarian reserve..
Sponsor
Bandare-abbas University of Medical Sciences
Enrollment
88
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Bandare-abbas University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Informed consent of the patient (completion of the patient consent form by the patient or the patient's companion)
  • •Patients aged 18 to 45 years.
  • •Patients who have no history of ovarian surgery or ovarian endometrioma.
  • •Normal sperm analysis
  • •POR (age over 40 years and/or a history of poor response to high\-dose stimulation with less than three oocytes and/or adverse ovarian reserve tests including AMH \< 1\.1 ng/nl; AFC \< 7\)
  • •Patients without endocrine disorders such as hyperprolactinemia, PCOS, etc.
  • •Non\-smoking patients
  • •Patients who do not have cardiovascular disorders.

Exclusion Criteria

  • •Adhesion or severe damage to the pelvis or ovaries
  • •Immunological diseases
  • •Hematological diseases
  • •Platelets less than one hundred and fifty thousand per cubic millimeter
  • •Systemic use of corticosteroids within two weeks before the procedure
  • •Taking anticoagulants

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Investigating the effectiveness of intraovarian injection of platelet rich plasma on ovarian reserve in infertile women due to decreased ovarian reserve
IRCT20160722029027N14Shahid Beheshti University of Medical Sciences15
Completed
Phase 2
Comparison of the effect of PRP versus PRP plus gonadotropin and gonadotropin alone on ovarian rejuvenation in patients with diminished ovarian reserve
IRCT20151013024512N7Deputy of Research and Development, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.45
Recruiting
Phase 2
Comparison of the effect of intraovarian injection of PRGF and PRP on improving the response and pregnancy outcomespatient with diminished ovarian reserve.
IRCT20160722029027N12Shahid Beheshti University of Medical Sciences30
Recruiting
Phase 3
Effectiveness evaluation of intra-ovarian injection of autologous menstrual blood stem cells in fertility potential of patients with poor ovarian response: a controlled clinical trial study
IRCT20180619040147N4Iranian academic center for education culture and research180
Recruiting
Phase 1
Investigating the effect of intraovarian injection of extracellular vesicles derived from bone marrow mesenchymal stromal cells in patients with premature ovarian failure.Premature ovarian failure.Primary ovarian failureE28.3
IRCT20080831001141N43otus Royan Charitable Fundation10